2 Apr 2009 11:53
Immunodiagnostic Systems Holdings plc
Notification under AIM Rule 17:
Immunodiagnostic Systems Holdings plc ("IDS" or "the Company") was notified on 1 April 2009 that Roger Duggan, Chief Executive Officer of the Company, had on the 31 March 2009 transferred 31,589 ordinary shares of 2p each in the Company ("Shares") from his personal account to his Self Invested Personal Pension.
The transfer was carried out at a price of 197.25p per Share.
Following this transaction Roger Duggan is deemed to have an unchanged total beneficial interest of 2,222,927 Shares. Roger Duggan's holding represents 8.41% of the total issued share capital of the Company.
For further information:
| IDS | Tel: 0191 519 0660 |
| Roger Duggan, CEO | www.idsplc.com |
| Paul Hailes, Finance Director | |
| Parkgreen Communications Ltd | Tel: 020 7933 8787 |
| Paul McManus | Mob: 07980 541 893 |
| paul.mcmanus@parkgreenmedia.com | |
| Oriel Securities Ltd | Nominated Advisor and joint broker |
| Richard Crawley or Gareth Price | Tel: 020 7710 7600 |
IDH.L (IDH)